Trade Name
Orphan Indication Patients having experienced a severe traumatic brain injury (Glasgow Coma Scale 3 to 8) in order to decrease early mortality and improve long-term functional and neurological outcome
USA Market Approval USA
USA Designation Date 2005-04-15 00:00:00
Sponsor Xytis, Inc.;400 South El Camino Real, Suite 1200;San Mateo, California, 94402